Bringing down the ROS: a new therapeutic approach for PPHN
- 1 December 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Lung Cellular and Molecular Physiology
- Vol. 295 (6) , L976-L978
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Superoxide dismutase restores eNOS expression and function in resistance pulmonary arteries from neonatal lambs with persistent pulmonary hypertensionAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2008
- Fasudil inhibits the myogenic response in the fetal pulmonary circulationAmerican Journal of Physiology-Heart and Circulatory Physiology, 2008
- Sildenafil for pulmonary hypertension in neonates2007
- Oxidant stress from uncoupled nitric oxide synthase impairs vasodilation in fetal lambs with persistent pulmonary hypertensionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2007
- Pulmonary vascular effects of nitric oxide-cGMP augmentation in a model of chronic pulmonary hypertension in fetal and neonatal sheepAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Heterozygous knockout of neuregulin-1 gene in mice exacerbates doxorubicin-induced heart failureAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- rhVEGF treatment preserves pulmonary vascular reactivity and structure in an experimental model of pulmonary hypertension in fetal sheepAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Endothelin-1 decreases endothelial NOS expression and activity through ETA receptor-mediated generation of hydrogen peroxideAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newbornThe Lancet, 1992
- Inhaled nitric oxide in persistent pulmonary hypertension of the newbornThe Lancet, 1992